GGrantIndex
← Leaderboards

Russell Ryan Kempker

Emory University

$3,115,410
Attributed
$4,682,259
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY201325
$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,682,259 · 7

By mechanism

R01$2,339,351 · 1
K23$910,116 · 1
D43$595,760 · 1
R21$369,140 · 1
K24$192,027 · 1
R03$167,963 · 1

Top collaborators

Most similar at Emory University

Same institution · by research overlap

Others in their field

Top investigators on “Tuberculosis

Research focus

TuberculosisInnovationCountryDrug ResistanceDrug Resistance In TuberculosisSiteFundingCohortTuberculosis TreatmentCessation Of LifeTuberculosis DrugsDrug KineticsPenetrationPharmaceutical PreparationsUnited States National Institutes Of HealthStructure Of Parenchyma Of LungNational Institute Of Allergy And Infectious DiseaseResistanceTissuesOperative Surgical ProceduresPublic HealthTranslational ResearchEnvironmentPulmonary Tuberculosis

Grant awards (16)

Cavity and Granuloma Oriented Inflammation and Tissue Pharmacokinetics in Pulmonary Tuberculosis (COOK TB)$762,816
R01 · FY2025 · AI · contact PI
Ethiopia-Emory TB Research Training Program$297,280
D43 · FY2025 · TW
EnhAncing Research and meNtoring Skills in Tuberculosis (EARN TB)$192,027
K24 · FY2025 · AI · contact PI
Cavity and Granuloma Oriented Inflammation and Tissue Pharmacokinetics in Pulmonary Tuberculosis (COOK TB)$762,667
R01 · FY2024 · AI · contact PI
Ethiopia-Emory TB Research Training Program$298,480
D43 · FY2024 · TW
Emory/Georgia TB Research Advancement Center (TRAC)$107,902
P30 · FY2024 · AI · contact PI
Cavity and Granuloma Oriented Inflammation and Tissue Pharmacokinetics in Pulmonary Tuberculosis (COOK TB)$813,868
R01 · FY2023 · AI · contact PI
An Exploratory Study of Anti-Tuberculosis Drug Penetration into Cerebrospinal Fluid$77,690
R03 · FY2019 · AI · contact PI
An Exploratory Study of Anti-Tuberculosis Drug Penetration into Cerebrospinal Fluid$90,273
R03 · FY2018 · AI · contact PI
A Clinical Pharmacology Study of a Novel Drug Regimen for Pre XDR and XDR Tuberculosis$193,545
R21 · FY2017 · AI · contact PI
Intra Cavitary Pharmacokinetics and Drug Resistance in Pulmonary Tuberculosis$188,676
K23 · FY2017 · AI · contact PI
Intra Cavitary Pharmacokinetics and Drug Resistance in Pulmonary Tuberculosis$180,360
K23 · FY2016 · AI · contact PI
A Clinical Pharmacology Study of a Novel Drug Regimen for Pre XDR and XDR Tuberculosis$175,595
R21 · FY2016 · AI · contact PI
Intra Cavitary Pharmacokinetics and Drug Resistance in Pulmonary Tuberculosis$180,360
K23 · FY2015 · AI · contact PI
Intra Cavitary Pharmacokinetics and Drug Resistance in Pulmonary Tuberculosis$180,360
K23 · FY2014 · AI · contact PI
Intra Cavitary Pharmacokinetics and Drug Resistance in Pulmonary Tuberculosis$180,360
K23 · FY2013 · AI · contact PI